In the last decades, numerous radiolabeled bombesin analogs for cancer diagnosis and therapy have been described, with 68Ga-RM2 [24,25], 68Ga-NeoBOMB1 [26,27], and 64Cu-SAR-BBN [28] presently being utilized in clinical trials. Here, GRP is linked to cancer.